This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción MRV
Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Competidores de Nuvo Pharmaceuticals Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.35 |
| 52 Week High | CA$1.55 |
| 52 Week Low | CA$0.50 |
| Beta | 0.78 |
| 1 Month Change | 3.05% |
| 3 Month Change | 104.55% |
| 1 Year Change | -8.78% |
| 3 Year Change | 136.84% |
| 5 Year Change | -58.46% |
| Change since IPO | -99.48% |
Noticias y actualizaciones recientes
Recent updates
Nuvo Pharmaceuticals (TSE:MRV) Has A Somewhat Strained Balance Sheet
Aug 17
Is Nuvo Pharmaceuticals (TSE:MRV) Using Too Much Debt?
Sep 01Nuvo Pharmaceuticals Inc.'s (TSE:MRV) CEO Might Not Expect Shareholders To Be So Generous This Year
May 11These 4 Measures Indicate That Nuvo Pharmaceuticals (TSE:MRV) Is Using Debt Extensively
Feb 22Rentabilidad de los accionistas
| MRV | CA Pharmaceuticals | Mercado CA | |
|---|---|---|---|
| 7D | 0.7% | 4.9% | 1.1% |
| 1Y | -8.8% | 44.3% | 7.5% |
Rentabilidad vs. Industria: MRV exceeded the Canadian Pharmaceuticals industry which returned -62.1% over the past year.
Rentabilidad vs. Mercado: MRV exceeded the Canadian Market which returned -11.7% over the past year.
Volatilidad de los precios
| MRV volatility | |
|---|---|
| MRV Average Weekly Movement | 26.8% |
| Pharmaceuticals Industry Average Movement | 14.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.1% |
Precio estable de las acciones: MRV's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: MRV's weekly volatility has increased from 21% to 27% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1983 | 101 | Jesse Ledger | www.miravohealthcare.com |
Resumen de fundamentos de Nuvo Pharmaceuticals Inc.
| Estadísticas fundamentales de MRV | |
|---|---|
| Capitalización bursátil | CA$15.37m |
| Beneficios(TTM) | CA$15.17m |
| Ingresos (TTM) | CA$72.42m |
1.0x
Ratio precio-beneficio (PE)0.2x
Ratio precio-ventas (PS)¿Está MRV sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MRV | |
|---|---|
| Ingresos | CA$72.42m |
| Coste de los ingresos | CA$27.36m |
| Beneficio bruto | CA$45.06m |
| Otros gastos | CA$29.89m |
| Beneficios | CA$15.17m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 1.33 |
| Margen bruto | 62.22% |
| Margen de beneficio neto | 20.95% |
| Ratio deuda/patrimonio | 1,149.7% |
¿Cómo se ha desempeñado MRV a largo plazo?
Ver rendimiento histórico y comparativa